Global market for antipsychotic drugs to reach $14.8 billion by 2014

The worldwide market for antipsychotic drugs is expected to reach $19.6 billion in 2010. With continued market penetration into new diseases and price increases for currently marketed antipsychotics, this market is expected to grow to a high of $20.8 billion in 2011 and then hit a low of $14.4 billion in 2013, before resuming growth again to $14.8 billion in worldwide sales for 2014.

Learn about the antipsychotic drug market, including regulatory issues; get a comprehensive assessment of the various products and technologies entering this market as well as marketing strategies being used to gain a competitive edge. Included in this report are forecasts for sales by product, company, geographic region, formulation, and indication (if possible) from 2010 through 2014, including supporting analyses for projections...

Use this report to:

• Learn about potential new antipsychotics with novel mechanisms of action or improved delivery systems that will provide powerful alternatives to currently prescribed drugs, and that could fill in for sales lost to generics
• Formulate innovative business strategies to differentiate products in the face of increasing generic competition in the 2011–2015 timeframe
• Identify which indications represent the greatest market opportunity as well as which drug candidates are the most promising to fill these unmet needs, the major challenges to their regulatory approval or market success, and their competitive profile
• Validate internal marketing plans with detailed 5-year sales forecasts for current and emerging branded antipsychotics.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.